Mitchell Cancer Institute — Mobile, Alabama

Public research footprint of Mitchell Cancer Institute, compiled from the ClinicalTrials.gov public registry.

158

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Malignant Solid Neoplasm · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Malignant Female Reproductive System Neoplasm · Triple-Negative Breast Carcinoma

Recently updated registry entries

NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)
NCT07365241 — A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706… (Recruiting)
NCT05564377 — Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mitchell Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.